Print    Email
Decrease (-) Restore Default Increase (+)
Bookmark and Share

Physician Bios

 If you have cancer or a serious blood disease, you need a caring physician and state-of-the-art care. The David Lee Cancer Center offers outstanding hematology-oncology physicians to guide your treatment.

Dr. Frame| Dr. Jubelirer | Dr. Cohen | Dr. Khalid | Dr. NagarajanDr. Rhodes


James N Frame MD, FACP 125x166

James N. Frame, MD, FACP
Medical Director


Dr. James Frame received his bachelor of arts degree from West Virginia Wesleyan College in 1977 and his medical degree from West Virginia University School of Medicine in 1981. He finished his internship and residency in internal medicine at the CAMC campus of the WVU School of Medicine in 1984.

Dr. Frame then completed a clinical fellowship in hematology/oncology from 1984 to 1987 at Memorial Sloan-Kettering Cancer Center in New York City. From 1985 to 1987 Dr. Frame completed a National Institute's of Health post-doctoral training fellowship in human immunogenetics at Sloan-Kettering Institute. He is board certified in internal medicine, medical oncology and hematology.

From 1987 to 1997, Dr. Frame served as attending physician in hematology/oncology and internal medicine while on active duty Navy service at National Naval Medical Center in Bethesda, MD. There he maintained an active clinical practice and was heavily involved in clinical research and the training of hematology and oncology fellows for the Navy and National Cancer Institute. From 1990 to 1997, Dr. Frame was fellowship program director in medical oncology at National Naval Medical Center and fellowship program director in hematology from 1994 to 1997. During that time, he also served as chief of the Divisions of Hematology and Medical Oncology, National Naval Medical Center.

Altogether, Dr. Frame has published more than 36 clinical, laboratory or book chapter manuscripts, 52 research abstracts and served as co-editor and contributing author for the textbook Hematology Oncology Therapy published by McGraw Hill in 2007. These publications have related to the treatment of breast cancer, lung cancer, leukemia, lymphoma and topics in bone marrow transplantation, cancer genetics, clotting and blood disorders. He has been invited as a peer reviewer of new manuscripts for several medical journals.

Dr. Frame returned to Charleston in 1997 where he served as medical director for oncology services at CAMC through 2002. He served as the founding chairperson for the West Virginia Comprehensive Cancer Control Coalition. Dr. Frame currently serves as medical director for the CAMC Cancer Center, president and board member for the West Virginia Oncology Society and chairman of CAMC's heparin-induced thrombocytopenia task force. He also is a clinical professor for West Virginia University School of Medicine-Charleston Division.
Back to top


 Steven J Jubelirer, MD, FACP 125x166

Steven J. Jubelirer, MD, FACP 



Dr. Steven Jubelirer received his bachelor of arts degree from the University of Wisconsin-Madison in 1970 and his medical degree from the University of Cincinnati in 1974. In 1977, he completed internship and residency training in internal medicine at Georgetown University Medical Center

in Washington, D.C. This was followed by fellowship training in hematology from 1977 to 1979 and a fellowship in clotting disorders from 1979 to 1980 at Boston University. Dr. Jubelirer is board certified in internal medicine, hematology and medical oncology. He also is certified by the International Academy of  emostasis, Thrombosis and Vascular Biology.

Dr. Jubelirer joined the West Virginia University School of Medicine and CAMC Memorial Hospital in 1981. He maintains a busy hematology/oncology practice, trains residents and actively conducts clinical hematology and oncology research. In the course of these activities, Dr. Jubelirer has published 72 peerreviewed clinical research manuscripts, 33 research abstracts, several invited manuscripts and two books. These publications have explored the clinical management of leukemia, melanoma, lymphomas, blood and coagulation disorders, as well as cancers of the lung, breast, cervix, colon, testis, prostate, liver, brain, pancreas and kidney.

Dr. Jubelirer serves on the editorial board for the Journal of Cancer Education and has been invited as a peer reviewer of new manuscripts for several medical journals. He also serves as principal investigator for the West Virginia Community Clinical Oncology Program, as chairman and founder of the Charleston Blood Club, and as director and founder of the CAMC comprehensive hemophilia  program. Dr. Jubelirer is principal investigator for clinical research programs in cooperation with the Eastern Cooperative Oncology Group and clinical research programs within the National Surgical Adjuvant Breast/Bowel Project. He also is senior research scientist for the CAMC Health Education and Research Institute in Charleston.
Back to top


Justin D. Cohen, MD, FACP 125x166 

Justin D. Cohen, MD, FACP



Dr. Justin Cohen received his bachelor of science degree in 1980 and his medical degree in 1981 from the honors program in medical education at Northwestern University in Chicago. He then completed an internship, an internal medicine residency and a cancer research fellowship at Northwestern University. In 1986, he was awarded an American Cancer Society fellowship in clinical cancer  treatment at the University of Wisconsin Cancer Center in Madison. This was followed by two more years of clinical oncology fellowship training at Wisconsin. Dr. Cohen then successfully competed for a National Cancer Institute Physician-Scientist Training Award from 1989 to 1991. He is board certified in internal medicine and medical oncology.

In 1991, Dr. Cohen joined the faculty at the University of Colorado Cancer Center in Denver. There he maintained an active hematology/ oncology practice, served as a teaching-attending in hematology/oncology, and supervised the training of hematology/oncology fellows. Dr. Cohen also served as director of the University of Colorado hematology/oncology residency training program and as chairman of the cancer matrix committee to coordinate cancer care activities.

From 1986 until 1998, Dr. Cohen maintained a successful cancer research  laboratory. He has published 35 peer-reviewed cancer research manuscripts, 22 research abstracts and multiple invited articles. These publications have involved the treatment of lymphomas, leukemias, breast, lung, brain, ovarian and uterine cancers, as well as radiation biology, the pharmacology of chemotherapy drugs and clinical applications of hyperthermia. For 13 years, Dr. Cohen was deeply involved in the development and clinical testing of experimental cancer therapies. He has been invited to be a peer reviewer of new manuscripts for 13 medical and scientific journals.

In 1997, Dr. Cohen decided to focus completely on patient care. He joined the CAMC Cancer Center in October 1998.
Back to top


 Ahmed A. Khalid, MD, FACP  125x166

Ahmed Khalid, MD

Dr. Ahmed Khalid completed undergraduate and medical training in 1988 at Rawalpindi Medical College in Rawalpindi, Pakistan, graduating with honors. He then entered a surgical residency at the Pakistan Institute of Medical Sciences.From 1993 through 1996, Dr. Khalid completed internal medicine training at St. Luke's-Roosevelt Hospital Center/ University Hospital of Columbia University College of Physicians and Surgeons in New York City. From 1996 through 2000, Dr. Khalid was in private practice in internal medicine in Lucedale, MS before starting fellowship training in hematology and oncology at the University of Arkansas for Medical Sciences in Little Rock, AR. After completing that training in 2004, he joined the CAMC Cancer Center. Dr. Khalid is board certified in internal medicine, hematology and medical oncology. He has a special interest in cancers of the lung, breast, head and neck, and gastrointestinal tract as well as the leukemias and lymphomas.
Back to top


 Arun Nagarajan, MD, FACP  125x166

Arun Nagarajan, MD, FACP


Dr. Arun Nagarajan received his medical degree with distinction from the  university of Mysore in Karnataka, India in 1995. From 1998 to 2001, he completed internship and residency training in internal medicine at Rush Presbyterian St. Luke's Medical Center in Chicago, IL and at West Suburban Hospital in Oak Park, IL where he also served as Associate Chief Resident. Dr. Nagarajan was then a fellow in hematology and oncology from 2001 through 2004 at the University of Arkansas for Medical Sciences in Little Rock, AR. During that time, he was awarded an Amgen Scholarship for excellence in hematology and oncology. Dr. Nagarajan joined the CAMC Cancer Center in 2004. He is board certified in internal medicine, medical oncology and hematology. His special interests include breast cancer, lung cancer, the leukemias and lymphomas, benign diseases of the blood, as well as communitybased clinical research trials. Dr. Nagarajan published an article in Community Oncology in 2007, and is one of the co-principal investigators for the Eastern Clinical Oncology Group of clinical trials at CAMC.
Back to top


Terrance Rhodes, MD, PhD  125x166

Terence Rhodes, MD, PhD

Dr. Terence Rhodes completed his bachelor of science degree at Marshall University.  He then participated in the Medical Scientist Training Program at West Virginia University.  During his basic science research years of the program, he trained at the National Cancer Institute in Maryland.  He was privileged to be mentored by Dr. Wei-Shau Hu, who trained under Nobel Laureate Dr. Howard Temin.  These years proved productive, allowing him to publish several papers in top tier journals in his field.  After successfully defending his PhD dissertation, he returned to West Virginia to finish his medical school training at WVU/CAMC.  He chose to stay in Charleston to complete his residency in Internal Medicine. Duke University Medical Center in Durham, NC accepted him into their hematology/medical oncology fellowship upon completion of residency. There he was able to return to basic science for part of his fellowship investigating molecular mechanisms involved in the tumor microenvironment and host-tumor interactions important for cancer progression.  Although he has years of basic science research experience, it is his interactions with patients he finds most fulfilling. Dr. Rhodes joined the CAMC Cancer Center in 2012.
Back to top

Our Mission: Striving to provide the best health care to every patient, every day.       © 2015 CAMC Health System, Inc.